Tags: 
After 25 years in South San Francisco, biopharmaceutical company and cancer drug developer Exelixis (NYSE: EXEL) has signed a 10-year lease with Ascentris to relocate its corporate headquarters to three buildings within The Waterfront in Alameda, CA.
The company will occupy 110,783 square feet across 1751, 1801 and 1851 Harbor Bay Pky., three low-rise office buildings that are part of the six-building, 385,000-square-foot The Waterfront office…